ALKBH3 and renal cell carcinoma: ALKBH3 is highly expressed in human tumors including prostate (Koike et al. 2012), non-small-cell lung (Tasaki et al. 2011), pancreatic (Yamato et al. 2012), and renal cell carcinoma (Hotta et al. 2015), and elevated ALKBH3 expression is associated with poor prognosis.